JOYCE CHUNG: Open Payments
NPI 1851944821 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 15 payments from 7 companies in 2025. Trend: 2023 $250 · 2024 $426 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $163 |
| Amgen Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Calliditas Therapeutics US Inc. | 2 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: TAVNEOS, XPHOZAH 30 MG, TARPEYO, IBSRELA, JARDIANCE, Rivfloza, Kerendia.
Industry payments across CA — which companies pay providers there.
